Tambac, Prince Jay V.
HRN: 26-06-99 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/16/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/16/2024
12/23/2024
IV
125mg
Q6H
PCAP C
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes